Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Financial Flexibility Index
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Financial Flexibility Index of 0.30x as of September 2024. Free cash flow of TL36.27 Million (operating CF TL33.37 Million minus capex TL2.91 Million) represents 0% of total liabilities (TL120.48 Million). Also explore Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Financial Flexibility Index (2020–2023)
Historical Financial Flexibility Index trend for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 4 annual periods. See ONCSM equity to assets ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
Year-by-year free cash flow to debt coverage for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For the full company profile including market capitalisation, see Oncosem Onkolojik Sistemler Sanayi ve Ti stock valuation.
| Year | Flexibility Index | Free Cash Flow (TRY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.06x | TL-6.54 Million | TL-38.10 Million | TL106.61 Million | ▼ -109.8% |
| 2022 | 0.63x | TL78.71 Million | TL52.69 Million | TL125.50 Million | ▼ -38.4% |
| 2021 | 1.02x | TL51.68 Million | TL51.68 Million | TL50.75 Million | ▲ +194.4% |
| 2020 | 0.35x | TL19.41 Million | TL19.41 Million | TL56.11 Million | — |